Form RW Curative Biotechnology

 

VIA EDGAR

 

December 22, 2025

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Christine Torney, Kevin Vaughn, Chris Edwards and Joe McCann

 

Re: Curative Biotechnology, Inc. Request to Withdraw Registration Statement on Form S-1 (File No. 333-279159)

 

Ladies and Gentlemen:

 

In accordance with Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), Curative Biotechnology, Inc. (the “Company”) hereby requests the withdrawal, effective as of the date hereof or as promptly as practicable, of the above-referenced registration statement (the “Registration Statement”), including all exhibits filed therewith and any amendments thereto. The Registration Statement was originally filed on May 6, 2024, and was amended on August 1, 2025.

 

The Company has determined not to pursue the sale of the securities covered by the Registration Statement at this time. The Company confirms that the Registration Statement was not declared effective and no securities have been sold pursuant to the Registration Statement.

 

The Company further requests that, in accordance with Rule 457(p) of the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.

 

Should you have any questions, or require any additional information, please do not hesitate to contact Scott Linsky of Lucosky Brookman LLP, counsel to the Company, at (732) 395-4408.

 

	Very truly yours,
		/s/ I Richard Garr
	Name:	I Richard Garr
	Title:	Chief Executive Officer

 

cc:	Scott Linsky, Lucosky Brookman LLP

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• cBrain expands U.S. market access through partnership with Carahsoft Technology Corporation
• Lynk Pharmaceuticals Announces Commercialization Collaboration with Simcere for Zemprocitinib in Dermatology Indications, Further Expanding Product Commercialization Footprint
• DSC Holdings Releases Inaugural China Used Car Industry White Paper: Used Car Transactions Approach New Car Sales as Residual Values and Dealer Economics Are Reshaped; AI's Role Expands